Each month our editorial team sifts through hundreds of papers and curates notable findings—for practitioners and informed readers who want to stay current with the evidence. Subscribe to the monthly Research Digest for expert analysis and concise summaries of key papers.
5 papers
This paper reviews the recent comeback of psychedelic research and points out that much of that work borrows from indigenous healing traditions. The authors say Indigenous people, ethnic and racial minorities, women, and other marginalized groups are often left out of research and the mainstream story about psychedelic medicine. The…
Recent, early-phase trials suggest psychedelics—especially psilocybin—may help treat several mental and substance use disorders. The psychedelic experience can include loss of self-importance, feelings of unity or connection, ineffable insights, and encounters with ‘deep’ reality or God, and it can change a person’s personality and worldview. The authors argue these unusual…
Psychedelic Harm Reduction and Integration (PHRI) is a clinical model for working with people who use or are thinking about using psychedelics. It blends harm-reduction therapy with methods from psychedelic-assisted therapy, can be used in short or ongoing psychotherapy, and aims to be compassionate and non-stigmatizing rather than focused only…
This ADDA article explains “high‑functioning ADHD” as when a person has ADHD symptoms but still manages daily life, often by using special strategies. It says high‑functioning ADHD is not an official diagnosis, can be hard to spot because coping methods hide symptoms, and that these workarounds can be tiring and…
This short paper, written by researchers, clinicians and people with lived experience, argues that thinking of eating disorders mainly as a problem of “control” is too simple. The authors say control can matter for some people, but making it the main story risks blaming the person, missing life events and…
